TITLE

Malignant Hyperthermia In The Indian Subcontinent: Non-availability Of Dantrolene - A Cause For Concern?

AUTHOR(S)
Pu, Jyotsna; Bhatnagar, Sushma; saxena, Abha
PUB. DATE
January 2002
SOURCE
Internet Journal of Pharmacology;2002, Vol. 1 Issue 1, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We report the first case of malignant hyperthermia from the Indian sub-continent and raise the issue of non-availability of dantrolene in a country, where this clinical entity was thought not to exist.
ACCESSION #
9876717

 

Related Articles

  • Sevoflurane.  // Reactions Weekly;2/27/2010, Issue 1290, p42 

    The article describes the case of a 16-year-old male patient who developed malignant hyperthermia (MH) after undergoing general anesthesia (GA) with sevoflurane. The patient suffered from fevers, hallucinations, agitation, and near-death experiences. Other symptoms were slowing ideomotor,...

  • Erstmanifestation einer fulminanten Malignen-Hyperthermie-Krise. Wejbora, M.; Bornemann-Cimenti, H.; Lessel, D.; Mandl, C.; Voit-Augustin, H.; Schwarz, G. // Anaesthesist;Jan2013, Vol. 62 Issue 1, p34 

    Malignant hyperthermia (MH) is a latent, autosomal dominant inherited syndrome of skeletal musculature which results in excessive hypermetabolism induced by halogenated anesthetic agents and depolarizing muscle relaxants and is caused by an uncontrolled intramuscular calcium release. This case...

  • Prevention and treatment of malignant hyperthermia in certified training hospitals in Japan: a questionnaire. Suyama, Hidemichi; Kawamoto, Masashi; Yuge, Osafumi // Journal of Anesthesia;2002, Vol. 16 Issue 3, p207 

    .Purpose. To assess the preparedness of hospitals in Japan for cases of malignant hyperthermia (MH).Method. A survey was sent to 884 training hospitals certified by the Japan Society of Anesthesiologists (JSA) in June and July 2000. Useful answers were received from 431 (48.8%)...

  • Malignant Hyperthermia in an Adult Trauma Patient. Elster, Eric A.; Harrison, John; Stasiewicz, Susan D.; Wang, Dennis; Golocovsky, Mario // American Surgeon;Oct2002, Vol. 68 Issue 10, p883 

    Presents the case of a 22-year-old male patient with malignant hyperthermia. Signs and symptoms; Treatment; Complications.

  • Association of hyperpyrexia with serious disease in children. Press, Shirley // Clinical Pediatrics;Jan1994, Vol. 33 Issue 1, p19 

    Investigates the incidence, sensitive indicators and types of illnesses encountered by 105 pediatric patients with hyperpyrexia. Pneumonia as the most common diagnosis; Death of four patients; Admission rate.

  • Malignant Hyperthermia Susceptibility and the Trauma Patient. Sheehan, Jacqueline A. // Military Medicine;Jun2005, Vol. 170 Issue 6, p510 

    Assorted casualties are expected from combat. Triage of the wounded may result in some going directly to surgery. Although every minute is essential, anesthetic care of these trauma patients must adhere to all established standards of care. A timely preoperative assessment must include...

  • Neuroleptic Malignant Syndrome: Response to Dantrolene Sodium. May, David C.; Morris, Stephan W.; Stewart, R. Malcolm; Fenton, Barry J.; Gaffney, F. Andrew // Annals of Internal Medicine;Feb83, Vol. 98 Issue 2, p183 

    Presents a case study of a patient with haloperidol-induced neuroleptic malignant syndrome. Clinical presentation of the patient; Efficacy of oral dantrolene sodium in treating the patient; Similarity between neuroleptic malignant syndrome and malignant hyperthermia; Physiological...

  • Hipertermia maligna: ¿cómo estar preparados? CORVETTO A., MARCIA; HEIDER M., ROSE; CAVALLIERI B., SILVANA // Revista Chilena de Cirugia;jun2013, Vol. 65 Issue 3, p279 

    Malignant hyperthermia is an autosomal dominant genetic disease that affects the skeletal muscle. Specifically corresponds to a hypermetabolic response against triggering agents such as halogenated gases and the muscle relaxant succinylcholine. Because MH is a potentially fatal disease and...

  • Analysis of human cultured myotubes responses mediated by ryanodine receptor 1. KOBAYASHI, M.; MUKAIDA, K.; MIGITA, T.; HAMADA, H.; KAWAMOTO, M.; YUGE, O. // Anaesthesia & Intensive Care;Mar2011, Vol. 39 Issue 2, p252 

    The article presents the conducted study to analyze the responses of human cultured myotubes that are mediated by ryanodine receptor 1 activators based on the Calcium-induced calcium release (Ca-induced Ca release) rate. The utility of the technique as an identifying test for predisposition to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics